Clinical Trial Detail

NCT ID NCT02614859
Title Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

prostate cancer

Therapies

Bicalutamide

Metformin

Age Groups: adult

No variant requirements are available.